Both in Pharmaceuticals
Capricor Therapeutics vs CytomX Therapeutics
Over the past year CAPR returned +47.2% and CTMX returned −42.5%; their daily moves had a correlation of 0.11.
CAPR +47.2% CTMX −42.5%Growth of $1, one year, split-adjusted
| Metric | CAPR | CTMX |
|---|---|---|
| Price | $8.92 | $2.35 |
| Market cap | $518.6M | $512.1M |
| Today | +8.25% | +7.80% |
| 1 month | +15.1% | −8.2% |
| 6 months | −74.1% | −43.1% |
| Year to date | −69.1% | −44.8% |
| 1 year | — | −40.2% |
| Revenue growth (YoY) | — | −92.4% |
| Gross margin | — | 100.0% |
| Net margin | — | −1457.4% |
| P/E (TTM) | — | — |
| Price / sales | — | 28.0× |
| Net cash | $237.9M | $330.3M |
| Dividend yield | — | — |
| Volatility (60d) | 144.1% | 69.6% |
| Short % of float | 48.4% | 21.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).